A combination of curcumin and EGCG synergistically inhibited the inflammatory mediator NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) compared to the individual chemicals in models using prostate and breast cancer cells [21]. The gene discussed is NFKB1; the disease is breast carcinoma.